Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M |
| Total Depreciation and Amortization | 28.00K | 23.00K | 2.00K | 2.04M | 825.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.85M | -1.75B | 753.96M | 1.53B | 3.23M |
| Change in Net Operating Assets | -15.54M | 3.16M | 5.06M | 4.63M | -2.64M |
| Cash from Operations | -38.25M | -22.80M | -53.66M | -35.18M | -31.07M |
| Capital Expenditure | -48.00K | -314.00K | -244.00K | -152.00K | -231.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 799.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -263.19M | -48.66M | -- | -1.00K | 1.00K |
| Cash from Investing | -263.24M | -48.97M | -244.00K | 646.00K | -230.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 75.00M | 483.08M | 22.21M | 97.00K | -- |
| Repurchase of Common Stock | -2.00K | -148.00K | -19.00K | -32.00K | -55.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -127.00K | -175.13M | -643.00K | 175.00M | -551.00K |
| Cash from Financing | 74.87M | 307.80M | 21.55M | 175.07M | -606.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.61M | 236.02M | -32.36M | 140.53M | -31.90M |